-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
-
Summary
-
Chinook Therapeutics, Inc. quarterly/annual Amortization of Intangible Assets history and growth rate from Q1 2015 to Q2 2023.
- Chinook Therapeutics, Inc. Amortization of Intangible Assets for the quarter ending June 30, 2023 was $433K, a 0.93% increase year-over-year.
- Chinook Therapeutics, Inc. Amortization of Intangible Assets for the twelve months ending June 30, 2023 was $1.73M, a 1.59% increase year-over-year.
- Chinook Therapeutics, Inc. annual Amortization of Intangible Assets for 2022 was $1.72M, a 2.08% increase from 2021.
- Chinook Therapeutics, Inc. annual Amortization of Intangible Assets for 2021 was $1.69M, a 300% increase from 2020.
- Chinook Therapeutics, Inc. annual Amortization of Intangible Assets for 2020 was $422K.
Amortization of Intangible Assets, Trailing 12 Months (USD)
Amortization of Intangible Assets, Quarterly (USD)
Amortization of Intangible Assets, YoY Quarterly Growth (%)